Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
- PMID: 9529250
- DOI: 10.1016/s0092-8674(00)81402-6
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
Abstract
Vascular endothelial growth factor (VEGF), a major regulator of angiogenesis, binds to two receptor tyrosine kinases, KDR/Flk-1 and Flt-1. We now describe the purification and the expression cloning from tumor cells of a third VEGF receptor, one that binds VEGF165 but not VEGF121. This isoform-specific VEGF receptor (VEGF165R) is identical to human neuropilin-1, a receptor for the collapsin/semaphorin family that mediates neuronal cell guidance. When coexpressed in cells with KDR, neuropilin-1 enhances the binding of VEGF165 to KDR and VEGF165-mediated chemotaxis. Conversely, inhibition of VEGF165 binding to neuropilin-1 inhibits its binding to KDR and its mitogenic activity for endothelial cells. We propose that neuropilin-1 is a novel VEGF receptor that modulates VEGF binding to KDR and subsequent bioactivity and therefore may regulate VEGF-induced angiogenesis.
Similar articles
-
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.J Biol Chem. 1996 Mar 8;271(10):5761-7. doi: 10.1074/jbc.271.10.5761. J Biol Chem. 1996. PMID: 8621443
-
Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.J Cell Biol. 1999 Jul 12;146(1):233-42. doi: 10.1083/jcb.146.1.233. J Cell Biol. 1999. PMID: 10402473 Free PMC article.
-
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.J Cell Biochem. 2002;85(2):357-68. doi: 10.1002/jcb.10140. J Cell Biochem. 2002. PMID: 11948691
-
Signaling pathways induced by vascular endothelial growth factor (review).Int J Mol Med. 2000 May;5(5):447-56. doi: 10.3892/ijmm.5.5.447. Int J Mol Med. 2000. PMID: 10762646 Review.
-
The splice variants of vascular endothelial growth factor (VEGF) and their receptors.J Cell Sci. 2001 Mar;114(Pt 5):853-65. doi: 10.1242/jcs.114.5.853. J Cell Sci. 2001. PMID: 11181169 Review.
Cited by
-
VEGF-Virus Interactions: Pathogenic Mechanisms and Therapeutic Applications.Cells. 2024 Nov 4;13(21):1815. doi: 10.3390/cells13211815. Cells. 2024. PMID: 39513922 Free PMC article. Review.
-
Aggravating mechanisms from COVID-19.Virol J. 2024 Sep 27;21(1):228. doi: 10.1186/s12985-024-02506-8. Virol J. 2024. PMID: 39334442 Free PMC article. Review.
-
A patient-derived cell model for malignant transformation in IDH-mutant glioma.Acta Neuropathol Commun. 2024 Sep 10;12(1):148. doi: 10.1186/s40478-024-01860-6. Acta Neuropathol Commun. 2024. PMID: 39256867 Free PMC article.
-
NRP1 knockdown inhibits the invasion and migration of rhabdoid tumor of the kidney cells.Pediatr Surg Int. 2024 Aug 12;40(1):221. doi: 10.1007/s00383-024-05808-8. Pediatr Surg Int. 2024. PMID: 39133317 Free PMC article.
-
Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth.ACS Chem Biol. 2024 Aug 16;19(8):1820-1835. doi: 10.1021/acschembio.4c00389. Epub 2024 Aug 4. ACS Chem Biol. 2024. PMID: 39099090 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases